Ecolab Inc v. SC Johnson Professional Group Limited

Court of Appeals for the Third Circuit·Decided July 20, 2026·No. 25-2033·Unpublished

Opinion

NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ________________

No. 25-2033 ________________

ECOLAB INC.; ECOLAB USA INC., Appellants

v.

SC JOHNSON PROFESSIONAL GROUP LIMITED, formerly known as DEB Group Limited; DEB IP LIMITED _____________

On Appeal from the United States District Court for the District of Delaware (D.C. Civil No. 1:23-cv-00170) District Judge: Honorable Richard G. Andrews ________________

Submitted Pursuant to Third Circuit L.A.R. 34.1(a) on March 24, 2026

Before: HARDIMAN, SCIRICA, and AMBRO, Circuit Judges.

(Filed: July 20, 2026) ________________

OPINION* ________________

* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not constitute binding precedent. SCIRICA, Circuit Judge

This case involves an interpretive dispute over a contract governing one

company’s right to enforce another company’s patents. Deb Group, now known as SC

Johnson Professional Group, granted Ecolab Inc. a non-exclusive license to make and sell

patented hand sanitizer and skin-care products. Deb also granted Ecolab the right to

bring suits against certain infringers of those same patents. However, Deb’s contract

limited that right. Under its terms, Ecolab required an affirmative written communication

from Deb granting permission to bring suit.

Ecolab contends it has the right to sue infringers of Deb’s patent under this

contractual provision. Accordingly, this dispute turns on whether Ecolab can show Deb

provided an affirmative written communication within the meaning of the contract.

Ecolab presented several theories at the District Court, but now only directs our attention

to a three-page 2022 letter from Deb. The District Court found this letter did not support

Ecolab’s claim, in part because Deb twice explicitly states in the letter it was not an

affirmative written communication. The Court dismissed the case and denied Ecolab’s

motion to amend its complaint. We agree, and, since we find Ecolab’s alternative

arguments unavailing, we will affirm.

I.1

The contract at issue is a patent license agreement resulting from two prior

1 We write principally for the parties, who are familiar with the factual context and legal history of this case. Therefore, we will set forth only those facts necessary to our analysis.

2 lawsuits between the parties—an original agreement in 2013 and an amendment to that

agreement in 2022. Collectively, these contracts granted Ecolab a non-exclusive, royalty-

bearing license to make and sell certain hand and skin-sanitizing products patented by

Deb.

These contracts also provided Ecolab with a conditional right to sue certain

infringers of Deb’s patents. Those conditions arise from both the original 2013 language

and the 2022 amendment language. Section 4.1 of the 2013 contract states:

[Deb] will take commercially reasonable steps to enforce its patents. Should [Deb] elect, at its sole discretion, to not enforce their own patents against a third party infringer, [Ecolab] shall have the right to assert the patents against such third party infringers at its own expense.

App. 739. The 2022 amendment added a new provision, Section 4.1(a), which reads:

[Deb] shall have no affirmative obligation to [Ecolab] pursuant to this Section 4.1 to take any steps to enforce its patents. No action or inaction other than an affirmative written communication of an election by [Deb] to [Ecolab’s designated counsel] shall be deemed an election by Deb Group not to enforce its patents pursuant to this Section 4.1. For purposes of clarity, Ecolab acknowledges that . . . silence by [Deb], or any absence of communication from [Deb], shall not be considered an affirmative communication of any election.

App. 779.

Just ten days after this amendment went into effect, Ecolab sent a letter asserting

Deb had provided an affirmative written communication permitting exercise of patent

enforcement rights under Section 4.1—within the amended contract itself.2 Deb replied it

2 The theory Ecolab pressed at the time—though strikingly similar to its current theory—was dismissed by the District Court and raised only “in passing” in a footnote of 3 had “not made, and [was] not making in this letter, an election not to enforce the Deb

Group Patents under Section 4.1 of the License Agreement.” App. 803. After another

letter from Ecolab, this round of communication culminated in a three-page letter from

Deb’s counsel, sent December 1, 2022, which is the subject of this case.3

Two passages from this December 1, 2022 letter are relevant to the resolution of

this case.

The first, which is the language Ecolab directs our attention to, requires a bit of

context. During prior exchanges between the companies, Ecolab had taken the position

the two latest-expiring patents covered by the license agreement would be invalid after

September 29, 2024 under a theory of obviousness-type double patenting,4 and

accordingly contended it should not have to pay royalties after that date to Deb.

Recognizing the obviousness-type double patenting issue, Deb stated it would not compel

Ecolab to pay royalties on those patents after September 29, 2024—a commitment it later

Ecolab’s brief before us and is accordingly forfeited. DLJ Mortg. Cap., Inc. v. Stevens, 167 F.4th 632, 635 (3d Cir. 2026) (citations omitted). 3 The three pages at issue begin with a one-page letter from Deb dated December 1, 2022. That letter incorporated by reference a two-page letter from Deb’s outside counsel dated November 30, 2022. The parties and the District Court package the two letters together in their discussion, and we will do likewise. 4 Obviousness-type double patenting is a judicially created doctrine which prevents one party from obtaining multiple patents that cover obvious variants of the same invention. It functions, in part, so an inventor cannot artificially extend the life of one patent by getting a second patent covering an obvious variation of the same invention with a later expiration date. See Gilead Scis., Inc. v. Natco Pharma Ltd., 753 F.3d 1208, 1212–14 (Fed. Cir. 2014); see generally Daniel Kazhdan, Obviousness-Type Double Patenting: Why It Exists and When It Applies, 53 AKRON L. REV. 1017, 1023–28 (2019).

4 formalized in the 2022 settlement. See App. 750 (“Deb Group confirms it will not seek

to enforce the [patents] in the United States, nor collect royalties thereon, for activities

carried out in the United States by Deb Group licensees on and after September 30,

2024.”). However, after securing freedom from royalties and potential enforcement by

Deb after September 29, 2024, Ecolab then asserted “at least some” claims from the two

patents were not subject to obviousness-type double patenting, and as such should still be

enforceable after September 29, 2024—by Ecolab. App. 809–10.

This brings us back to the December 1, 2022 letter. Deb, responding in the letter

to Ecolab’s latest claim, pushed back on the idea “at least some” patents were immune

from challenge by writing:

In any event, for the avoidance of doubt, [Deb] has independently analyzed all claims of the [patents] and has concluded that all are subject to an invalidity challenge due to obviousness type double patenting beyond September 29, 2024.

App. 818. Ecolab contends this language satisfied the written communication

requirement under Section 4.1 of the amended 2022 contract.

Free access — add to your briefcase to read the full text and ask questions with AI

Ecolab Inc v. SC Johnson Professional Group Limited, (3d Cir. 2026).

Ecolab Inc v. SC Johnson Professional Group Limited (Ecolab Inc v. SC Johnson Professional Group Limited) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Axis Reinsurance Co. v. Hlth Corp.
993 A.2d 1057 (Supreme Court of Delaware, 2010)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.
616 A.2d 1192 (Supreme Court of Delaware, 1992)
Gilead Sciences, Inc. v. Natco Pharma Limited
753 F.3d 1208 (Federal Circuit, 2014)
Ina Collins v. Mary Kay Inc
874 F.3d 176 (Third Circuit, 2017)
Mission Product Holdings, Inc. v. Tempnology, LLC
587 U.S. 370 (Supreme Court, 2019)
Celgene Corporation v. Peter
931 F.3d 1342 (Federal Circuit, 2019)
Ram Construction Co. v. American States Insurance
749 F.2d 1049 (Third Circuit, 1984)
Don Ascolese v. Shoemaker Construction Co
55 F.4th 188 (Third Circuit, 2022)